- Formulary


	NHS BaNES CCG, NHS Swindon CCG, NHS Wiltshire CCG Royal United Hospitals Bath NHS Foundation Trust Great Western Hospitals NHS Foundation Trust Salisbury NHS Foundation Trust

Introduction

Welcome to the BaNES, Swindon and Wiltshire Joint Formulary
For use by primary, secondary & community care prescribers within BaNES, Swindon & Wiltshire
See about page for information relating to the three formularies which have merged to make this
new BSW joint formulary and for traffic light definitions.

To use this formulary, search by medicine name, condition [use search box below] or BNF chapter/subsection [use chapter tab]. For further information see QRG - how to use BSW formulary website and QRG - how to use BSW formulary App

Useful Links

COVID-19 RESOURCES

NICE: COVID-19 Rapid Guidelines and Rapid Evidence Summaries

SPS: Summary of COVID-19 medicines recommendations from professional bodies (requires log in, free for NHSemail)

SPS: Guidance on management of drugs requiring monitoring during Covid-19 (requires log in, free for NHSemail)

BSWCCG: COVID-19 intranet page

NEW 03/04/2020 End Of Life Prescribing for those unable to take oral medication during COVID-19 outbreak Guidance agreed with BSW hospices (Dorothy House, Prospect and Salisbury). Options that can be used depending on availability of syringe drivers, anyone to administer SC injections, or using patches/buccal/sub-lingual routes.

NEW 03/04/2020 COVID-19 BSW Meds Optimisation issues. Covers antibiotic use, COPD, asthma and oxygen.

Prescribing Guidelines	Shared Care Guidance	BSW Management of infections in Primary Care Regularly updated - we suggest not printing Full Guideline Quick Ref Guide adults Quick Ref Guide children
BaNES CCG Medicines Management Information	Swindon CCG Medicines Management Information	Wiltshire CCG Medicines Management Information
Royal United Hospitals Bath NHS Foundation Trust intranet link	Great Western Hospitals NHS Foundation Trust intranet link	Salisbury NHS Foundation Trust [link coming soon]

News Feed

- Covid-19: Guidance for the public here.
- Covid-19: Guidance for HCPs here.

During Covid-19 outbreak, submit reports of suspected side effects to medicines or medical devices using the Yellow Card Scheme electronically via Yellow Card website or free app [from Apple App Store or Google Play Store] to enable early identification of trends.

25th March 2020 - MHRA statement on cloroquine and hydroxychloroquine for COVID-19 - Until we have clear, definitive evidence that these treatments are safe and effective for the treatment of COVID-19, chloroquine and hydroxychloroquine should only be used for this purpose within a clinical trial.

27 Mar 2020 - Safe switching of warfarin to DOACs for patients with NVAF and VTE (DVT / PE) during the coronavirus pandemic

Mar 2020 - Ulipristal (Esmya) removed from formulary: suspension of license due to risk of serious liver injury

Mar 2020 - MHRA DSU Tofacitinib (Xeljanz▼): new measures to minimise risk of VTE and of serious and fatal infections

Mar 2020 - MHRA DSU Baricitinib (Olumiant▼): risk of venous thromboembolism

>>> more news

Website constantly under development. Report inaccuracies/feedback at bsw.formulary@nhs.net

A number of ‘differences’ in formulary options, traffic light statuses, prescribing guidelines and shared care protocols have yet to be agreed across BSW. Please bear with us as we work to review these and please follow the guidance for your locality.

The formulary is intended to be used when prescribing for adolescents and adults.

All material on this website is aimed at healthcare professionals working in BaNES, Swindon and Wiltshire, but is information currently held within the public domain.

Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or out of hours contact the NHS 111 service by telephoning 111.

Visits = 37168

Last updated: 06/04/2020 14:21:57..